Novel genetic screen provides clues on how a parasite bests the immune system

Researchers from Osaka University developed an in vivo CRISPR screen to analyze factors affecting Toxoplasma gondii fitness in healthy and immunodeficient mice. Mice were infected with Toxoplasma containing CRISPR libraries that targeted specific genes; genetic sequencing was then performed to identify which genes are important to fitness. The genetic screen clarified the contributions of host genetics and parasite genetics and can contribute to the development of strategies for toxoplasmosis treatment and prevention.

Fig. 1
Transmission electronic microscopy image of Toxoplasma gondii

Researchers from Osaka University develop a highly reproducible, in vivo genetic screen to identify factors that help the parasite Toxoplasma gondii evade the immune system in mice

 Osaka, Japan – While the presence of harmful critters in your home may be addressed by a call to the exterminator, harmful parasites in the body can be much harder to expel. A single-celled parasite known as Toxoplasma gondii (hereafter Toxoplasma) commonly infects humans and other animals, and the resulting condition, known as toxoplasmosis, can cause severe health issues in people with weakened immune systems. Recently, researchers in Japan have developed a tool to investigate how Toxoplasma promotes its survival within a host, shedding new light on potential strategies for the treatment and prevention of toxoplasmosis.  

 In a new study published in Cell Reports, researchers from Osaka University conducted a genetic screen using CRISPR technology in mice to confirm known genes and identify new genes involved in Toxoplasma fitness, i.e., the ability of the parasite to survive and thrive within a host. CRISPR genome editing is a method in which short fragments of genetic material known as guide RNAs (gRNAs) are utilized to modify specific sequences of DNA in the genome.

 CRISPR screens, in which many gRNAs are used to systematically modify target genes in an organism, can be used to infer which genes are involved in a specific biological process. The research team aimed to use a CRISPR screen in Toxoplasma-infected mice to identify virulence factors, which are traits that help Toxoplasma evade the host immune system. While virulence factors associated with Toxoplasma have been previously identified in hosts with healthy immune systems, these factors have not been fully explored in hosts with weakened immune systems.

Fig. 2
Host genetics is combined with parasite genetic screening

“When Toxoplasma infection occurs, the host’s immune system responds by producing a protein known as interferon-γ (IFN-γ), which stimulates other molecules to help prevent Toxoplasma from multiplying,” explains senior author Masahiro Yamamoto. “We performed our CRISPR screen in both healthy mice and immunocompromised mice that lack the receptor for IFN-γ, which allowed us to evaluate the effects of both host genetics and parasite genetics on immune-related virulence factors.” 

 The researchers infected mice with Toxoplasma; these Toxoplasma contained gRNA libraries that affected certain genes of interest. Later, the team extracted Toxoplasma from the mice and evaluated the gene expression of the parasite. This analysis allowed the research team to identify which genes seem to promote Toxoplasma fitness, and also facilitated comparison of gene expression between healthy and immunodeficient mice.

 “Our highly reproducible, in vivo screen identified both IFN-γ-dependent and IFN-γ-independent fitness genes that are involved in the promotion of Toxoplasma virulence,” says lead author Yuta Tachibana. “We successfully identified many virulence factors of Toxoplasma.”

 These genes represent potential targets for the treatment and prevention of Toxoplasma infection. Additionally, the research team’s method of in vivogenetic screening can serve as a foundation for the development of new therapeutics and vaccines for toxoplasmosis. 

 ###

 The article, “Host genetics highlights IFN-γ-dependent Toxoplasma genes encoding secreted and non-secreted virulence factors in in vivo CRISPR screens,” was published in Cell Reports at DOI: https://doi.org/10.1016/j.celrep.2023.112592

Fig. 3
Schematic of in vivo CRISPR screen of Toxoplasma

About Osaka University

Osaka University was founded in 1931 as one of the seven imperial universities of Japan and is now one of Japan's leading comprehensive universities with a broad disciplinary spectrum. This strength is coupled with a singular drive for innovation that extends throughout the scientific process, from fundamental research to the creation of applied technology with positive economic impacts. Its commitment to innovation has been recognized in Japan and around the world, being named Japan's most innovative university in 2015 (Reuters 2015 Top 100) and one of the most innovative institutions in the world in 2017 (Innovative Universities and the Nature Index Innovation 2017). Now, Osaka University is leveraging its role as a Designated National University Corporation selected by the Ministry of Education, Culture, Sports, Science and Technology to contribute to innovation for human welfare, sustainable development of society, and social transformation.

Website: https://resou.osaka-u.ac.jp/en

Published: 06 Jun 2023

Institution:

Contact details:

Global Strategy Unit

1-1 Yamadaoka, Suita,Osaka 565-0871, Japan

Country: 
Journal:
News topics: 
Content type: 
Website: 
Funding information:

Japan Agency for Medical Research and Development